Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Hsin Liu

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
JCO Precision Oncology|May 26, 2021
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous ResponsesSheng-Fang Su, Chia-Hsin Liu, Chiou-Ling Cheng, et al.
Nucleic Acids Research|November 13, 2023
DriverDBv4: a multi-omics integration database for cancer driver gene researchChia-Hsin Liu, Yo-Liang Lai, Pei-Chun Shen, et al.
International Journal of Molecular Sciences|November 13, 2021
Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data AnalysisPai-Chi Teng, Shu-Pin Huang, Chia-Hsin Liu, et al.
Cancer Cell International|December 9, 2022
LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1Feng-Chih Kuo, Yu-Ting Wang, Chia-Hsin Liu, et al.
Cancers|March 25, 2022
Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics AnalysisYo-Liang Lai, Chia-Hsin Liu, Shu-Chi Wang, et al.
Computational and Structural Biotechnology Journal|September 12, 2022
Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinomaChia-Hsin Liu, Shu-Hsuan Liu, Yo-Liang Lai, et al.
Oncotarget|January 30, 2016
EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinomaHsuan-Yu Chen, Chia-Hsin Liu, Ya-Hsuan Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutationsShinsheng Yuan, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical ActionabilityHsuan-Yu Chen, Sung-Liang Yu, Bing-Ching Ho, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
JCO Precision Oncology|May 26, 2021
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous ResponsesSheng-Fang Su, Chia-Hsin Liu, Chiou-Ling Cheng, et al.
Nucleic Acids Research|November 13, 2023
DriverDBv4: a multi-omics integration database for cancer driver gene researchChia-Hsin Liu, Yo-Liang Lai, Pei-Chun Shen, et al.
International Journal of Molecular Sciences|November 13, 2021
Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data AnalysisPai-Chi Teng, Shu-Pin Huang, Chia-Hsin Liu, et al.
Cancer Cell International|December 9, 2022
LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1Feng-Chih Kuo, Yu-Ting Wang, Chia-Hsin Liu, et al.
Cancers|March 25, 2022
Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics AnalysisYo-Liang Lai, Chia-Hsin Liu, Shu-Chi Wang, et al.
Computational and Structural Biotechnology Journal|September 12, 2022
Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinomaChia-Hsin Liu, Shu-Hsuan Liu, Yo-Liang Lai, et al.
Oncotarget|January 30, 2016
EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinomaHsuan-Yu Chen, Chia-Hsin Liu, Ya-Hsuan Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutationsShinsheng Yuan, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical ActionabilityHsuan-Yu Chen, Sung-Liang Yu, Bing-Ching Ho, et al.
Pageof 6